(276 days)
No
The summary describes passive electrodes for signal acquisition and does not mention any computational processing, analysis, or algorithms, let alone AI/ML.
No.
The device is intended for stimulating/recording biopotential signals (EEG, EMG, EP) for diagnostic purposes, not for treating a condition.
No
The device is described as electrodes used for recording, monitoring, and stimulating biopotential signals (EEG, EMG, EP). While these signals can be used for diagnosis by other equipment, the device itself is a signal acquisition component, not a diagnostic device that interprets the signals to provide a diagnosis.
No
The device description explicitly states it is a physical electrode with adhesive gel and lead wires, which are hardware components. The performance studies also focus on physical properties like biocompatibility and electrical properties.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, tissue) to provide information about a person's health. This testing is done outside of the body (in vitro).
- Device Description: The DAEHAN Adhesive Surface Electrodes are applied to the patient's skin to record or stimulate biopotential signals. This is a non-invasive, in vivo (within the living body) application.
- Intended Use: The intended use is for stimulating/recording biopotential signals like EEG, EMG, and EP, which are measurements taken directly from the body.
The device is used for physiological monitoring and stimulation, not for testing samples taken from the body.
N/A
Intended Use / Indications for Use
The DAEHAN Adhesive Surface Electrodes are intended for use with recording, monitoring and stimulation equipment for the purpose of stimulating/recording of biopotential signals. Electrodes are applied in the study of biopotentials such as Electroencephalograph (EEG), surface Electromyography (EMG), nerve conduction and Evoked potential signals (EP). Electrodes are non-invasive as they are applied to the, patient's skin using a self-adhesive solid-gel surface. The electrodes are non-sterile and for single patient use only.
Product codes
GXY
Device Description
DAEHAN Adhesive Surface Electrodes are non-invasive. Cutaneous devices are used in the acquisition of signals for the purpose of stimulating, monitoring and recording Electroencephalograph (EEG), surface Electromyography (EMG) and Evoked Potentials (EP). The electrodes are designed for single-patient/multiple application use and are very flexible. Because of the adhesive nature of the gel, no securing material is required for fixating the electrode to the patient's skin. The electrodes with lead wire have a safety DIN 42802 connector, several lengths and color combinations.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Surface
Indicated Patient Age Range
Adult
Intended User / Care Setting
Prescription Use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
- Biocompatibility
- ISO 10993-5: Biological evaluation of medical devices Part 5: tests for in vitro cytotoxicity
- ISO 10993-10: Biological evaluation of medical devices Part 10: tests for irritation and skin sensitization
- Performance Testing
- Electrical property: AAMI/ANSI EC12 : Disposable ECG Electrodes.
- Shelf-life Testing
- ASTM F1980-02, Standard guide for accelerated aging of sterile medical device package.
- Basic Safety and Essential Performance
- Electrical Safety: AAMI/ANSI ES 60601-1:2005/(R)2012, CL 8.5.2.3 : Patient Leads DAEHAN Adhesive Surface Electrodes were tested in accordance to the test requirements and test methods of subclause 8.5.2.3 of IEC 60601-1:2005 and are in conformance with AAMI/ANSI ES 60601-1:2005. The differences between IEC 60601-1:2005 and AAMI/ANSI ES 60601-1:2005 do not alter the safety and effectiveness of DAEHAN Adhesive Surface Electrodes.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.1320 Cutaneous electrode.
(a)
Identification. A cutaneous electrode is an electrode that is applied directly to a patient's skin either to record physiological signals (e.g., the electroencephalogram) or to apply electrical stimulation.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health and Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
November 1, 2018
Daehan Medical Systems Co., Ltd. Da Pin Jeong R&A Manager 250 Okgucheondong-Ro Siheung-City, Gyeonggido Republic of Korea 15084
Re: K180247
Trade/Device Name: DAEHAN Adhesive Surface Electrodes Regulation Number: 21 CFR 882.1320 Regulation Name: Cutaneous Electrode Regulatory Class: Class II Product Code: GXY Dated: August 6, 2018 Received: August 10, 2018
Dear Da Pin Jeong:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Vivek J. Pinto -S
for Carlos L. Peña, PhD, MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K180247
Device Name DAEHAN Adhesive Surface Electrodes
Indications for Use (Describe)
The DAEHAN Adhesive Surface Electrodes are intended for use with recording, monitoring and stimulation equipment for the purpose of stimulating/recording of biopotential signals. Electrodes are applied in the study of biopotentials such as Electroencephalograph (EEG), surface Electromyography (EMG), nerve conduction and Evoked potential signals (EP). Electrodes are non-invasive as they are applied to the, patient's skin using a self-adhesive solid-gel surface. The electrodes are non-sterile and for single patient use only.
| Type of Use ( Select one or both, as applicable ) |
|---|
| ---------------------------------------------------------- |
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for DAEHAN MEDICAL SYSTEMS Co., Ltd. The logo is in blue and includes the company name. The image also includes the company's telephone and fax numbers: TEL: +82-31-432-6275, FAX: +82-31-432-6276.
Rev.2
250 Okgucheondong-Ro, Siheung-City, Gyeonggido, Republic of Korea, 15084
510(k) Summary
[As required by 21 CFR 807.92]
1. Date Prepared [21 CFR 807.92(a)(a)]
Dec. 22. 2017
2. Submitter's Information [21 CFR 807.92(a)(1)]
| ● | Name of Sponsor: | Daehan Medical Systems Co., Ltd. | |
|---|---|---|---|
| - | Address: | 250 Okgucheondong-Ro, Siheung-City, Gyeonggido, | |
| 15084, Republic of Korea | |||
| ● | Contact Name: | Da Pin Jeong / RA Manager | |
| - | Telephone No.: | +82-31-432-6275 | |
| - | Fax No.: | +82-31-432-6276 | |
| - | Email Address: | dpjeong@dmsleadwire.com |
- Establishment Registration No.: . 3002893037
- . Name of Manufacturer: Same as Sponsor . Address: Same as Sponsor
Trade Name, Regulation Name, Classification [21 CFR 807.92(a)(2)] 3.
- . Trade Name: DAEHAN Adhesive Surface Electrodes
- Regulation Name: Cutaneous electrode
- Classification:
| Classification Panel | Neurology |
|---|---|
| Classification Regulation | 21 CFR 882.1320 |
| Product Code | GXY |
| Device Class | II |
4
Image /page/4/Picture/0 description: The image shows the logo for DAEHAN MEDICAL SYSTEMS Co., Ltd. The logo is in blue and features the word "DAEHAN" in a stylized font. Below the word "DAEHAN" is the text "DAEHAN MEDICAL SYSTEMS Co., Ltd." in a smaller font. There is also a blue symbol above the word "DAEHAN".
250 Okgucheondong-Ro, Siheung-City, Gyeonggido, Republic of Korea, 15084
TEL: +82-31-432-6275 FAX: +82-31-432 Rev.2
Identification of Predicate Device(s) [21 CFR 807.92(a)(3)] 4.
The identified predicate device within this submission is shown as follow;
- 510(k) Number: K073532 ●
●
Applicant:
- Technomed Europe
- Regulation Name: Cutaneous electrode
- . Device Name: Disposable Adhesive Surface Electrodes
There are no significant differences between the DAEHAN Adhesive Surface Electrodes and the predicate device that would adversely affect the use of the product. It is substantially equivalent to these devices in design, function, and technical characteristics.
5. Description of the Device [21 CFR 807.92(a)(4)]
DAEHAN Adhesive Surface Electrodes are non-invasive. Cutaneous devices are used in the acquisition of signals for the purpose of stimulating, monitoring and recording Electroencephalograph (EEG), surface Electromyography (EMG) and Evoked Potentials (EP). The electrodes are designed for single-patient/multiple application use and are very flexible. Because of the adhesive nature of the gel, no securing material is required for fixating the electrode to the patient's skin. The electrodes with lead wire have a safety DIN 42802 connector, several lengths and color combinations.
6. Intended Use [21 CFR 807.92(a)(5)]
The Disposable Adhesive Surface Electrodes are intended for use with recording, monitoring and stimulation equipment for the purpose of stimulating/recording of biopotential signals. Electrodes are applied in the study of biopotentials such as Electroencephalograph (EEG), surface Electromyography (EMG), nerve conduction and Evoked potential signals (EP). Electrodes are non-invasive as they are applied to the, patient's skin using a self-adhesive solidgel surface. The electrodes are non-sterile and for single patient use only.
5
Image /page/5/Picture/0 description: The image shows the logo for DAEHAN MEDICAL SYSTEMS Co., Ltd. The word "DAEHAN" is written in a large, sans-serif font, with the letters connected to each other. Below the word "DAEHAN" is the text "DAEHAN MEDICAL SYSTEMS Co., Ltd." in a smaller font. There is a small graphic of a plus sign made of four smaller plus signs in the upper right corner of the logo.
250 Okgucheondong-Ro, Siheung-City, Gyeonggido, Republic of Korea, 15084
TEL: +82-31-432-6275, FAX: +82-31-432-6276 Rev.2
7. Technological Characteristics [21 CFR 807.92(a)(6)]
The DAEHAN Adhesive Surface Electrodes are based on a technical feature comparison, the proposed device was found to be similar to predicate device with regard to design, function, and technical characteristics.
| Proposed Device | Predicate Device | |
|---|---|---|
| K Number | K073532 | |
| Model | DAEHAN Adhesive Surface Electrodes | Disposable Adhesive Surface Electrodes |
| Manufacturer | Daehan Medical Systems Co., Ltd. | Technomed Europe |
| Device Class | Class II | Class II |
| Product code | GXY | GXY |
| Intended Use | The DAEHAN Adhesive Surface | |
| Electrodes are intended for use with | ||
| recording, monitoring and | ||
| stimulation equipment for the purpose | ||
| of stimulating/recording of | ||
| biopotential signals. Electrodes | ||
| are applied in the study of | ||
| biopotentials such as | ||
| Electroencephalograph (EEG), surface | ||
| Electromyography (EMG), nerve | ||
| conduction and Evoked potential | ||
| signals (EP). Electrodes are | ||
| non-invasive as they are applied to the, | ||
| patient's skin using a self-adhesive | ||
| solid-gel surface. The | ||
| electrodes are non-sterile and for | ||
| single patient use only. | The Disposable Adhesive Surface | |
| Electrodes are intended for use with | ||
| recording, monitoring and | ||
| stimulation equipment for the purpose | ||
| of stimulating/recording of | ||
| biopotential signals. Electrodes | ||
| are applied in the study of | ||
| biopotentials such as | ||
| Electroencephalograph (EEG), surface | ||
| Electromyography (EMG), nerve | ||
| conduction and Evoked potential | ||
| signals (EP). Electrodes are | ||
| non-invasive as they are applied to the, | ||
| patient's skin using a self-adhesive | ||
| solid-gel surface. The | ||
| electrodes are non-sterile and for | ||
| single patient use only. | ||
| Anatomical sites | Surface | Surface |
| Patch Area | 20 and 40*50mm | 20 and 40*50mm |
| Patient population | Adult | Adult |
| Conductive surface area | 12.56cm² and 20cm² | 12.56cm² and 20cm² |
| Lead Wire Length | 1.0 and 2.0m | 1.0 and 2.0m |
| Construction electrode | Three layers |
- Top sheet : Non woven Fabric
- Conductive film: Carbon film coated with silver chloride
- Conductive hydrogel | Three layers
- Top sheet : Non woven Fabric
- Conductive film: Carbon film coated with silver chloride
- Conductive hydrogel |
| Lead wire material | PVC insulated tin plated with copper | PVC insulated tin plated with copper |
| PH | 3.5~7.0 | 6.5+/-0.5 |
| Impedance |